Clinical Development Doctors Drug Trials Vaccination 
pharmaphorum
MAY 14, 2021
China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. But Reuters reported that the doctor identified as its principal clinical trial investigator has said he is not in charge of the trial.
pharmaphorum
DECEMBER 1, 2022
As the industry focuses on creating a more holistic, inclusive patient experience, here are key steps to consider in order to help bridge the gap between clinical research and the patient experience. The fact is, many minorities never learn about vital clinical trials in play, or that they’re eligible to participate.
Expert insights. Personalized for you.
52 
Let's personalize your content